Pulmonary fungal infection in paediatric cancer patients

H. A. El-Mahallawy, I. A. Attia, S. Abo-El-Naga, N. Hassan, A. E. Salem (Cairo, Egypt)

Source: Annual Congress 2001 - Immune deficiencies and the lung in childhood
Session: Immune deficiencies and the lung in childhood
Session type: Oral Presentation
Number: 3432
Disease area: Respiratory infections

Congress or journal article abstract

Abstract

Pulmonary fungal infection is a serious complication among cancer patients who receive chemotherapy. In order to identify the type of causative fungi and to evaluate the frequency and outcome of pulmonary fungal infection among paediatric cancer patients, this study was conducted during a complete year (1999) in National Cancer Institute in Egypt. Out of 1917 suspected infectious episodes, fungal infections were clinically and microbiologically documented in 70 patients.
Forty patients with acute leukemia, 15 lymphoma patients and 15 patients with solid tumors were evaluated for the extent of the disease, the duration of hospitalization, neutropenia and the current or previous chemotherapy. Bronchial lavage samples were obtained by transtracheal aspiration or bronchoscopy and bronchoalveolar lavage. Candida strains were identified utilizing Chromagar media and Fungifast Twin kits (Stago Group, France).
Among 70 patients evaluated in this study pulmonary fungal infection was microbiologically diagnosed in 25 patients. Meanwhile, peripheral vein blood culture was positive for fungal infection in 18 patients. The most frequently reported candida species were C. parapsilosis (14 cases) and C. tropicalis (13 cases). Cryptococcus neoformans was isolated from 7 cases and Aspergillus species in 13. Yet, fungemia and pulmonary fungal infection are associated with high mortality rate.


Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
H. A. El-Mahallawy, I. A. Attia, S. Abo-El-Naga, N. Hassan, A. E. Salem (Cairo, Egypt). Pulmonary fungal infection in paediatric cancer patients. Eur Respir J 2001; 16: Suppl. 31, 3432

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Fungal lung infections in critically-ill patients
Source: International Congress 2016 – PG19 The lung in the septic critically-ill patient
Year: 2016



Pulmonary infections in neutropenic patients
Source: Eur Respir J 2003; 22: Suppl. 45, 334s
Year: 2003

Invasive pulmonary aspergillosis in patients with severe COPD. Compative study between probable invasive infection and colonization
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011


The prevalence of mycobacterial and fungal pulmonary infections in patients submitted to hepatic transplant
Source: Eur Respir J 2004; 24: Suppl. 48, 702s
Year: 2004

Secondary pulmonary mycoses etiology agent species diversity in patients with tuberculosis and in patients with HIV infection
Source: Virtual Congress 2020 – Mechanism or pathways of chronic lung diseases
Year: 2020


A possible association between breast cancer, bronchiectasis and nontuberculous mycobacterial (NTM) lung disease
Source: International Congress 2014 – Resistance, bacteriological profile and comorbidities in respiratory infections
Year: 2014

Respiratory tuberculosis in lung cancer patients
Source: Annual Congress 2009 - Tuberculosis: metabolism and comorbidities
Year: 2009

Lung cancer in patients with medical history of pulmonary tuberculosis
Source: Annual Congress 2008 - Problems in managing pulmonary and extrapulmonary tuberculosis
Year: 2008

The coexistance of active pulmonary tuberculosis in lung cancer patients
Source: Annual Congress 2007 - Epidemiology of tuberculosis II
Year: 2007


Cavitary formation in non-tuberculous mycobacterial infection is the significant risk for development to chronic pulmonary aspergillosis
Source: International Congress 2014 – Cells, biofilms and biomarkers in respiratory infections
Year: 2014


Pulmonary nontuberculous mycobacerial disease in elderly patients
Source: Virtual Congress 2020 – Non-tuberculous mycobacterial infections and bronchiectasis
Year: 2020


Pulmonary tuberculosis in elderly patients
Source: Eur Respir J 2007; 30: Suppl. 51, 418s
Year: 2007

Pulmonary infection with nontuberculous mycobacteria: management and follow up of 5 infected patients
Source: Annual Congress 2009 - Treatment and prevention of lower respiratory tract infections
Year: 2009


Lung resection in hematologic patients with pulmonary invasive fungal disease: Changing pattern in recent years
Source: Annual Congress 2012 - Surgery for infections and congenital diseases
Year: 2012

Reasons for late diagnostics of lung cancer in pulmonary tuberculosis patients
Source: Annual Congress 2012 - Tuberculosis: clinical findings III
Year: 2012


Invasive pulmonary aspergillosis in immunocompetent patients acquired during renovation in a chest institute
Source: International Congress 2017 – Respiratory infections in critically ill and immuno-depressed patientes
Year: 2017


Pulmonary fungal infection in immunocompetent vs immunocompromised patients - a retrospective study
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014

Lung resection for invasive pulmonary aspergillosis in neutropenic patients – risks and outcome
Source: Annual Congress 2008 - Aetiology of respiratory infections: mycobacteria and fungi
Year: 2008

Pulmonary cryptococcosis in patients without HIV infection: analysis of 14 cases
Source: Eur Respir J 2005; 26: Suppl. 49, 410s
Year: 2005

Pulmonary infection with nocardia species in chronic respiratory patients: a report of 12 cases
Source: Eur Respir J 2006; 28: Suppl. 50, 560s
Year: 2006